作者
- Antman, E.M. (105)
- Braunwald, E. (54)
- Cannon, C.P. (23)
- Gibson, C.M. (25)
- Giugliano, R.P. (21)
- McCabe, C.H. (36)
- Morrow, D.A. (33)
- Murphy, S.A. (26)
- Sabatine, M.S. (15)
- de Lemos, J.A. (22)
|
總筆數:105
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Low-molecular-weight heparin therapy for non-ST-elevation acute coronarysyndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.-G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Impact of diabetes mellitus on epicardial and microvascular flow afterfibrinolytic therapy |
Angeja, B.G.;de Lemos, J.;Murphy, S.A.;Marble, S.J.;Antman, E.M.;Cannon, C.P.;Braunwald, E.;Gibson, C.M.;TIMI Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Low-molecular-weight heparin therapy for non-ST-elevation acutecoronary syndromes and during percutaneous coronary intervention: An expertconsensus^* |
Kereiakes, D.J.;Montalescot, G.;Antman, E.M.;Cohen, M.;Darius, H.;Ferguson, J.J.;Grines, C.;Karsch, K.R.;Kleiman, N.S.;Moliterno, D.J.;Steg, P.G.;Teirstein, P.;Van de Werf, F.;Wallentin, L.; |
American Heart Journal |
2002-10-01 |
查看 |
| Impact of diabetes mellitus on epicardial and microvascular flow afterfibrinolytic therapy |
Angeja, B.G.;de Lemos, J.;Murphy, S.A.;Marble, S.J.;Antman, E.M.;Cannon, C.P.;Braunwald, E.;Gibson, C.;TIMI Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method foridentifying patients with a patent infarction-related artery afterfibrinolytic administration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Direct comparison of characteristics, treatment, and outcomes of patientsenrolled versus patients not enrolled in a clinical trial at centersparticipating in the TIMI 9 Trial and TIMI 9 Registry |
Bahit, M.C.;Cannon, C.P.;Antman, E.M.;Murphy, S.A.;Gibson, C.M.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2003-01-01 |
查看 |
| Safety and efficacy of unfractionated heparin versus enoxaparin in patientswho are obese and patients with severe renal impairment: analysis from theESSENCE and TIMI 11B studies |
Spinler, S.A.;Inverso, S.M.;Cohen, M.;Goodman, S.G.;Stringer, K.A.;Antman, E.M.;ESSENCE and TIMI 11B Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Angiographic and clinical characteristics associated with the developmentof q-wave and non-q-wave myocardial infarction in the thrombolysis inmyocardial infarction (timi) 14 trial |
Murphy, S.A.;Dauterman, K.;de Lemos, J.A.;Kermgard, S.;Antman, E.M.;Braunwald, E.;Gibson, C.M.;Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Safety and efficacy of unfractionated heparin versus enoxaparin inpatients who are obese and patients with severe renal impairment: analysisfrom the ESSENCE and TIMI 11B studies |
Spinler, S.A.;Inverso, S.M.;Cohen, M.;Goodman, S.G.;Stringer, K.A.;Antman, E.M.;ESSENCE and TIMI 11B Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Angiographic and clinical characteristics associated with thedevelopment of q-wave and non-q-wave myocardial infarction in thethrombolysis in myocardial infarction (timi) 14 trial |
Murphy, S.A.;Dauterman, K.;de Lemos, J.A.;Kermgard, S.;Antman, E.M.;Braunwald, E.;Gibson, C.;Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Low molecular weight heparins for acute coronary syndrome: tackling theissues head-on |
Antman, E.M.; |
American Heart Journal |
2003-08-01 |
查看 |
| Combining enoxaparin and glycoprotein IIb/IIIa antagonists for thetreatment of acute coronary syndromes: final results of the NationalInvestigators Collaborating on Enoxaparin-3 (NICE-3) study |
Ferguson, J.J.;Antman, E.M.;Bates, E.R.;Cohen, M.;Every, N.R.;Harrington, R.A.;Pepine, C.J.;Theroux, P.;NICE-3 Investigators; |
American Heart Journal |
2003-10-01 |
查看 |
| Glycoprotein IIb/IIIa inhibitors in patients with unstableangina/non-ST-segment elevation myocardial infarction: Appropriateinterpretation of the guidelines |
Antman, E.M.; |
American Heart Journal |
2003-10-01 |
查看 |
| Combining enoxaparin and glycoprotein IIb/IIIa antagonists for thetreatment of acute coronary syndromes: final results of the NationalInvestigators Collaborating on Enoxaparin-3 (NICE-3) study |
Ferguson, J.J.;Antman, E.M.;Bates, E.R.;Cohen, M.;Every, N.R.;Harrington, R.A.;Pepine, C.J.;Theroux, P.;NICE-3 Investigators; |
American Heart Journal |
2003-10-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Validated risk score predicts the development of congestive heart failureafter presentation with unstable angina or non-ST-elevation myocardialinfarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 |
Wylie, J.V.;Murphy, S.A.;Morrow, D.A.;de Lemos, J.A.;Antman, E.M.;Cannon, C.P.; |
American Heart Journal |
2004-07-01 |
查看 |
| Angiographic perfusion score: An angiographic variable that integrates bothepicardial and tissue level perfusion before and after facilitatedpercutaneous coronary intervention in acute myocardial infarction |
Gibson, C.M.;Murphy, S.A.;Morrow, D.A.;Aroesty, J.M.;Gibbons, R.J.;Gourlay, S.G.;Barron, H.V.;Giugliano, R.P.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2004-08-01 |
查看 |
| Angiographic perfusion score: An angiographic variable that integrates bothepicardial and tissue level perfusion before and after facilitatedpercutaneous coronary intervention in acute myocardial infarction |
Gibson, C.M.;Murphy, S.A.;Morrow, D.A.;Aroesty, J.M.;Gibbons, R.J.;Gourlay, S.G.;Barron, H.V.;Giugliano, R.P.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2004-08-01 |
查看 |
| Acute ST-segment elevation myocardial infarction and prior stroke: Ananalysis from the Magnesium in Coronaries (MAGIC) trial |
Cooper, H.A.;Domanski, M.J.;Rosenberg, Y.;Norman, J.;Scott, J.H.;Assmann, S.F.;McKinlay, S.M.;Hochman, J.S.;Antman, E.M.;the MAGIC Trial Investigators; |
American Heart Journal |
2004-12-01 |
查看 |
| Acute ST-segment elevation myocardial infarction and prior stroke: Ananalysis from the Magnesium in Coronaries (MAGIC) trial |
Cooper, H.A.;Domanski, M.J.;Rosenberg, Y.;Norman, J.;Scott, J.H.;Assmann, S.F.;McKinlay, S.M.;Hochman, J.S.;Antman, E.M.;the MAGIC Trial Investigators; |
American Heart Journal |
2004-12-01 |
查看 |
| Acute ST-segment elevation myocardial infarction and prior stroke: Ananalysis from the Magnesium in Coronaries (MAGIC) trial |
Cooper, H.A.;Domanski, M.J.;Rosenberg, Y.;Norman, J.;Scott, J.H.;Assmann, S.F.;McKinlay, S.M.;Hochman, J.S.;Antman, E.M.;the MAGIC Trial Investigators; |
American Heart Journal |
2004-12-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction -Design and rationale for the Enoxaparin and Thrombolysis Reperfusion forAcute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarctionstudy 25 (ExTRACT-TIMI 25) |
Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.;for the ExTRACT-TIMI 25 Investigators; |
American Heart Journal |
2005-02-01 |
查看 |
| Enoxaparin versus unfractionated heparin as antithrombin therapy inpatients receiving fibrinolysis for ST-elevation myocardial infarction |
for the ExTRACT-TIMI 25 Investigators;Antman, E.M.;Morrow, D.A.;McCabe, C.H.;Jiang, F.;White, H.D.;Fox, K.A.A.;Sharma, D.;Chew, P.;Braunwald, E.; |
American Heart Journal |
2005-02-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographic findingsin non-ST-elevation acute coronary syndromes: Observations from thePlatelet Receptor Inhibition in Ischemic Syndrome Management in PatientsLimited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.-Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographicfindings in non-ST-elevation acute coronary syndromes: Observations fromthe Platelet Receptor Inhibition in Ischemic Syndrome Management inPatients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Correlation between the TIMI risk score and high-risk angiographicfindings in non-ST-elevation acute coronary syndromes: Observations fromthe Platelet Receptor Inhibition in Ischemic Syndrome Management inPatients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial |
Mega, J.L.;Morrow, D.A.;Sabatine, M.S.;Zhao, X.Q.;Snapinn, S.M.;DiBattiste, P.M.;Gibson, C.M.;Antman, E.M.;Braunwald, E.;Theroux, P.; |
American Heart Journal |
2005-05-01 |
查看 |
| Tenecteplase and tirofiban in ST-segment elevation acute myocardialinfarction: Results of a randomized trial |
for the FASTER (TIMI 24) Investigators;Ohman, E.M.;Van de Werf, F.;Antman, E.M.;Califf, R.M.;de Lemos, J.A.;Gibson, C.M.;Oliverio, R.L.;Harrelson, L.;McCabe, C.;DiBattiste, P.;Braunwald, E.; |
American Heart Journal |
2005-07-01 |
查看 |
| Tenecteplase and tirofiban in ST-segment elevation acute myocardialinfarction: Results of a randomized trial |
for the FASTER (TIMI 24) Investigators;Ohman, E.M.;Van de Werf, F.;Antman, E.M.;Califf, R.M.;de Lemos, J.A.;Gibson, C.M.;Oliverio, R.L.;Harrelson, L.;McCabe, C.;DiBattiste, P.;Braunwald, E.; |
American Heart Journal |
2005-07-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Combination of quantitative ST deviation and troponin elevationprovides independent prognostic and therapeutic information in unstableangina and non-ST-elevation myocardial infarction |
Sabatine, M.S.;Morrow, D.A.;McCabe, C.H.;Antman, E.M.;Gibson, C.M.;Cannon, C.P.; |
American Heart Journal |
2006-01-01 |
查看 |
| Predicting a late positive serum troponin in initiallytroponin-negative patients with non-ST-elevation acute coronary syndrome:Clinical predictors and validated risk score results from the TIMI IIIB andGUSTO IIA studies |
Januzzi, J.L.;Newby, L.K.;Murphy, S.A.;Pieper, K.;Antman, E.M.;Morrow, D.A.;Sabatine, M.S.;Ohman, E.M.;Cannon, C.P.;Braunwald, E.; |
American Heart Journal |
2006-02-01 |
查看 |
| Evaluation of prasugrel compared with clopidogrel in patients withacute coronary syndromes: design and rationale for the TRial to assessImprovement in Therapeutic Outcomes by optimizing platelet InhibitioN withprasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) |
for the TRITON-TIMI 38 Investigators;Wiviott, S.D.;Antman, E.M.;Gibson, C.M.;Montalescot, G.;Riesmeyer, J.;Weerakkody, G.;Winters, K.J.;Warmke, J.W.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Evaluation of prasugrel compared with clopidogrel in patients withacute coronary syndromes: design and rationale for the TRial to assessImprovement in Therapeutic Outcomes by optimizing platelet InhibitioN withprasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) |
for the TRITON-TIMI 38 Investigators;Wiviott, S.D.;Antman, E.M.;Gibson, C.M.;Montalescot, G.;Riesmeyer, J.;Weerakkody, G.;Winters, K.J.;Warmke, J.W.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2006-10-01 |
查看 |
| Global outcomes of ST-elevation myocardial infarction: Comparisons ofthe Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial InfarctionTreatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)registry and trial |
Steinberg, B.A.;Moghbeli, N.;Buros, J.;Ruda, M.;Parkhomenko, A.;Raju, B.S.;Garcia-Castillo, A.;Janion, M.;Nicolau, J.C.;Fox, K.A.A.;Morrow, D.A.;Gibson, C.M.;Antman, E.M.; |
American Heart Journal |
2007-07-01 |
查看 |
| Global outcomes of ST-elevation myocardial infarction: Comparisons ofthe Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial InfarctionTreatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)registry and trial |
Steinberg, B.A.;Moghbeli, N.;Buros, J.;Ruda, M.;Parkhomenko, A.;Raju, B.S.;Garcia-Castillo, A.;Janion, M.;Nicolau, J.C.;Fox, K.A.A.;Morrow, D.A.;Gibson, C.M.;Antman, E.M.; |
American Heart Journal |
2007-07-01 |
查看 |
| Effect of enoxaparin versus unfractionated heparin in diabetic patientswith ST-elevation myocardial infarction in the Enoxaparin and ThrombolysisReperfusion for Acute Myocardial Infarction Treatment-Thrombolysis InMyocardial Infarction study 25 (ExTRACT-TIMI 25) trial |
from the TIMI Study Group;Morrow, D.A.;Antman, E.M.;Murphy, S.A.;Qin, J.;Ruda, M.;Guneri, S.;Jacob, A.J.;Budaj, A.;Braunwald, E.; |
American Heart Journal |
2007-12-01 |
查看 |
| Effect of enoxaparin versus unfractionated heparin in diabetic patientswith ST-elevation myocardial infarction in the Enoxaparin and ThrombolysisReperfusion for Acute Myocardial Infarction Treatment-Thrombolysis InMyocardial Infarction study 25 (ExTRACT-TIMI 25) trial |
from the TIMI Study Group;Morrow, D.A.;Antman, E.M.;Murphy, S.A.;Qin, J.;Ruda, M.;Guneri, S.;Jacob, A.J.;Budaj, A.;Braunwald, E.; |
American Heart Journal |
2007-12-01 |
查看 |
| Effect of prasugrel versus clopidogrel on outcomes among patients withacute coronary syndrome undergoing percutaneous coronary interventionwithout stent implantation: A TRial to assess Improvement in TherapeuticOutcomes by optimizing platelet inhibitioN with prasugrel(TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy |
for the TIMI Study Group;Pride, Y.B.;Wiviott, S.D.;Buros, J.L.;Zorkun, C.;Tariq, M.U.;Antman, E.M.;Braunwald, E.;Gibson, C.M.; |
American Heart Journal |
2009-09-01 |
查看 |
| Effect of prasugrel versus clopidogrel on outcomes among patients withacute coronary syndrome undergoing percutaneous coronary interventionwithout stent implantation: A TRial to assess Improvement in TherapeuticOutcomes by optimizing platelet inhibitioN with prasugrel(TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy |
for the TIMI Study Group;Pride, Y.B.;Wiviott, S.D.;Buros, J.L.;Zorkun, C.;Tariq, M.U.;Antman, E.M.;Braunwald, E.;Gibson, C.M.; |
American Heart Journal |
2009-09-01 |
查看 |
| Extent of ST-segment resolution after fibrinolysis adds improved riskstratification to clinical risk score for ST-segment elevation myocardialinfarction |
Harkness, J.R.;Sabatine, M.S.;Braunwald, E.;Morrow, D.A.;Sloan, S.;Wiviott, S.D.;Giugliano, R.P.;Antman, E.M.;Cannon, C.P.;Scirica, B.M.; |
American Heart Journal |
2010-01-01 |
查看 |
| Evaluation of the novel factor Xa inhibitor edoxaban compared withwarfarin in patients with atrial fibrillation: Design and rationale for theEffective aNticoaGulation with factor xA next GEneration in AtrialFibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI48) |
Ruff, C.T.;Giugliano, R.P.;Antman, E.M.;Crugnale, S.E.;Bocanegra, T.;Mercuri, M.;Hanyok, J.;Patel, I.;Shi, M.;Salazar, D.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2010-10-01 |
查看 |
| Evaluation of the novel factor Xa inhibitor edoxaban compared withwarfarin in patients with atrial fibrillation: Design and rationale for theEffective aNticoaGulation with factor xA next GEneration in AtrialFibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI48) |
Ruff, C.T.;Giugliano, R.P.;Antman, E.M.;Crugnale, S.E.;Bocanegra, T.;Mercuri, M.;Hanyok, J.;Patel, I.;Shi, M.;Salazar, D.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2010-10-01 |
查看 |
| Untangling the relationship between medication adherence andpost-myocardial infarction outcomes |
Choudhry, N.K.;Glynn, R.J.;Avorn, J.;Lee, J.L.;Brennan, T.A.;Reisman, L.;Toscano, M.;Levin, R.;Matlin, O.S.;Antman, E.M.;Shrank, W.H.; |
American Heart Journal |
2014-01-01 |
查看 |
|
|
|
